The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.
 
Kieuhoa T. Vo
No Relationships to Disclose
 
Jennifer G. Michlitsch
No Relationships to Disclose
 
Avanthi T. Shah
No Relationships to Disclose
 
Joel M. Reid
No Relationships to Disclose
 
Sarah A. Burhow
No Relationships to Disclose
 
Eloise M. Graham
No Relationships to Disclose
 
Fabienne Hollinger
No Relationships to Disclose
 
Matthew A. Zapala
No Relationships to Disclose
 
Janel Long-Boyle
No Relationships to Disclose
 
Mi-Ok Kim
No Relationships to Disclose
 
Katherine K. Matthay
Honoraria - EUSA Pharma; Progenics
 
Steven G. DuBois
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc